Aptose Biosciences Inc (APTO) - Financial and Strategic SWOT Analysis Review

September 2021 | 61 pages | ID: A773A3B346CEN
GlobalData

Abstracts

Aptose Biosciences Inc (APTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aptose Biosciences Inc (Aptose) is a clinical-stage biotechnology company that focuses on developing personalized therapies for the treatment of life-threatening cancers including, acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), certain B-cell malignancies, and other hematologic malignancies. The company’s cancer therapeutics pipeline products include CG-806, a FLT3/BTK kinase inhibitor; APTO-253, a MYC oncogene inhibitor and APL-581, a dual BET Bromodomain-Kinase Inhibitor. Its small molecule cancer therapeutics pipeline product programs are designed to provide single agent benefit. The company operates in Canada and the US and has collaborations with biopharmaceutical companies and healthcare centers for the development and commercialization of its pipeline product programs. Aptose is headquartered in San Diego, California, the US.

Aptose Biosciences Inc Key Recent Developments

Aug 03,2021: Aptose Reports Results for the Second Quarter 2021
Jul 20,2021: Aptose to Report Second Quarter 2021 Financial Results and Hold Conference Call on Tuesday, August 3, 2021
May 12,2021: Aptose to Present at Upcoming Investor Conferences
Mar 31,2021: Aptose to Report First Quarter 2021 Financial Results and Hold Conference Call on Tuesday, May 4, 2021
Mar 16,2021: Aptose Expands Senior Leadership Team

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Aptose Biosciences Inc - Key Facts
Aptose Biosciences Inc - Key Employees
Aptose Biosciences Inc - Key Employee Biographies
Aptose Biosciences Inc - Major Products and Services
Aptose Biosciences Inc - History
Aptose Biosciences Inc - Company Statement
Aptose Biosciences Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Aptose Biosciences Inc - Business Description
Aptose Biosciences Inc - Corporate Strategy
Aptose Biosciences Inc - SWOT Analysis
SWOT Analysis - Overview
Aptose Biosciences Inc - Strengths
Aptose Biosciences Inc - Weaknesses
Aptose Biosciences Inc - Opportunities
Aptose Biosciences Inc - Threats
Aptose Biosciences Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Aptose Biosciences Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 03, 2021: Aptose Reports Results for the Second Quarter 2021
Jul 20, 2021: Aptose to Report Second Quarter 2021 Financial Results and Hold Conference Call on Tuesday, August 3, 2021
May 12, 2021: Aptose to Present at Upcoming Investor Conferences
Mar 31, 2021: Aptose to Report First Quarter 2021 Financial Results and Hold Conference Call on Tuesday, May 4, 2021
Mar 16, 2021: Aptose Expands Senior Leadership Team
Mar 02, 2021: Aptose to Release Fourth Quarter and Year End December 31, 2020 Financial Results and Hold Conference Call on March 23, 2021
Dec 31, 2020: Aptose Reports Results for the Fourth Quarter and Full Year 2020
Dec 06, 2020: Aptose presents highlights from ASH and corporate update event
Nov 10, 2020: Aptose reports results for the third quarter 2020
Aug 04, 2020: Aptose reports results for the second quarter 2020

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Aptose Biosciences Inc, Key Facts
Aptose Biosciences Inc, Key Employees
Aptose Biosciences Inc, Key Employee Biographies
Aptose Biosciences Inc, Major Products and Services
Aptose Biosciences Inc, History
Aptose Biosciences Inc, Other Locations
Aptose Biosciences Inc, Subsidiaries
Aptose Biosciences Inc, Key Competitors
Aptose Biosciences Inc, Ratios based on current share price
Aptose Biosciences Inc, Annual Ratios
Aptose Biosciences Inc, Annual Ratios (Cont...1)
Aptose Biosciences Inc, Interim Ratios
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Aptose Biosciences Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Aptose Biosciences Inc, Performance Chart (2016 - 2020)
Aptose Biosciences Inc, Ratio Charts
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Aptose Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021